Company intelligence / Profile preview

Esteve

Barcelona, Catalonia, Spainesteva.eu ↗

Ownership: Private
Development stage: Other

Overview

Esteve is a leading international pharmaceutical company focused on specialty medicines, particularly in rare diseases. Recent clinical results include the acquisition of a biologic for severe primary insulin-like growth factor 1 deficiency and three products targeting Cushing’s syndrome and adrenocortical carcinoma. The company is expanding its commercial portfolio through strategic acquisitions and licensing agreements to address high unmet medical needs in rare diseases.

Therapeutic areas: OncologyEndocrinology
Modalities: Small moleculeBiologic
Industry: Biotech

Partnerships

Recent licensing agreement for severe IGF-I deficiency treatmentPartnerships with pharma/biotech companies as part of CDMO business model

Beyond the preview

Go deeper on Esteve.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esteve.

Explore the full profile